Table 8 Mentions, rejections and endorsements of reasons concerning downstream effects (Category D)

D.1: Individual medical safety might be infringed

Mention [4, 49, 54, 66]

Reject [82, 85]

Endorse [8, 19, 35]

D.2.i: Findings and substances may threaten general biosafety^a

Mention [14, 26, 27, 54, 85]

Reject [2, 72]

Endorse [89]

D.2.ii: Funding chimera research may contradict distributive justice^b

Mention [24, 89]

Reject [13, 82]

Endorse [none]